ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2019/02/21 | 5,130 | 5,150 | 5,020 | 5,080 | +20 | +0.4% | 661,800 |
| 2019/02/20 | 5,070 | 5,120 | 5,010 | 5,060 | +20 | +0.4% | 455,200 |
| 2019/02/19 | 4,990 | 5,090 | 4,985 | 5,040 | +10 | +0.2% | 616,900 |
| 2019/02/18 | 5,050 | 5,120 | 5,000 | 5,030 | +95 | +1.9% | 912,900 |
| 2019/02/15 | 4,825 | 4,950 | 4,740 | 4,935 | +65 | +1.3% | 807,300 |
| 2019/02/14 | 4,800 | 4,935 | 4,760 | 4,870 | +95 | +2% | 1,153,700 |
| 2019/02/13 | 4,760 | 4,790 | 4,720 | 4,775 | +75 | +1.6% | 612,400 |
| 2019/02/12 | 4,700 | 4,735 | 4,680 | 4,700 | +135 | +3% | 678,800 |
| 2019/02/08 | 4,660 | 4,685 | 4,525 | 4,565 | -180 | -3.8% | 855,500 |
| 2019/02/07 | 4,765 | 4,815 | 4,705 | 4,745 | +5 | +0.1% | 750,200 |
| 2019/02/06 | 4,700 | 4,755 | 4,685 | 4,740 | +20 | +0.4% | 712,700 |
| 2019/02/05 | 4,700 | 4,725 | 4,650 | 4,720 | -10 | -0.2% | 807,400 |
| 2019/02/04 | 4,650 | 4,755 | 4,645 | 4,730 | +120 | +2.6% | 883,800 |
| 2019/02/01 | 4,605 | 4,630 | 4,555 | 4,610 | -25 | -0.5% | 565,800 |
| 2019/01/31 | 4,570 | 4,690 | 4,550 | 4,635 | +130 | +2.9% | 1,110,100 |
| 2019/01/30 | 4,525 | 4,540 | 4,420 | 4,505 | -135 | -2.9% | 1,771,300 |
| 2019/01/29 | 4,495 | 4,655 | 4,470 | 4,640 | +115 | +2.5% | 727,300 |
| 2019/01/28 | 4,515 | 4,580 | 4,495 | 4,525 | +5 | +0.1% | 544,400 |
| 2019/01/25 | 4,550 | 4,610 | 4,490 | 4,520 | -40 | -0.9% | 832,100 |
| 2019/01/24 | 4,420 | 4,570 | 4,330 | 4,560 | +315 | +7.4% | 1,453,300 |
| 2019/01/23 | 4,320 | 4,405 | 4,215 | 4,245 | -95 | -2.2% | 938,700 |
| 2019/01/22 | 4,375 | 4,450 | 4,320 | 4,340 | -30 | -0.7% | 620,000 |
| 2019/01/21 | 4,535 | 4,545 | 4,350 | 4,370 | -115 | -2.6% | 662,300 |
| 2019/01/18 | 4,490 | 4,555 | 4,470 | 4,485 | ±0 | ±0% | 645,300 |
| 2019/01/17 | 4,475 | 4,535 | 4,435 | 4,485 | +15 | +0.3% | 575,100 |
| 2019/01/16 | 4,405 | 4,505 | 4,395 | 4,470 | +85 | +1.9% | 714,500 |
| 2019/01/15 | 4,375 | 4,535 | 4,370 | 4,385 | -100 | -2.2% | 855,800 |
| 2019/01/11 | 4,620 | 4,650 | 4,460 | 4,485 | -35 | -0.8% | 639,900 |
| 2019/01/10 | 4,605 | 4,745 | 4,510 | 4,520 | -85 | -1.8% | 1,183,900 |
| 2019/01/09 | 4,520 | 4,645 | 4,470 | 4,605 | +120 | +2.7% | 1,138,100 |
| 2019/01/08 | 4,480 | 4,660 | 4,415 | 4,485 | +75 | +1.7% | 1,111,000 |
| 2019/01/07 | 4,430 | 4,495 | 4,385 | 4,410 | +150 | +3.5% | 867,400 |
| 2019/01/04 | 4,240 | 4,385 | 4,230 | 4,260 | -80 | -1.8% | 923,100 |
| 2018/12/28 | 4,335 | 4,390 | 4,270 | 4,340 | -110 | -2.5% | 982,100 |
| 2018/12/27 | 4,380 | 4,510 | 4,300 | 4,450 | +350 | +8.5% | 948,400 |
| 2018/12/26 | 4,140 | 4,235 | 4,010 | 4,100 | +80 | +2% | 821,800 |
| 2018/12/25 | 4,080 | 4,180 | 3,965 | 4,020 | -265 | -6.2% | 937,300 |
| 2018/12/21 | 4,370 | 4,450 | 4,195 | 4,285 | -45 | -1% | 971,100 |
| 2018/12/20 | 4,615 | 4,640 | 4,255 | 4,330 | -355 | -7.6% | 1,402,900 |
| 2018/12/19 | 4,455 | 4,700 | 4,415 | 4,685 | +205 | +4.6% | 897,200 |
| 2018/12/18 | 4,635 | 4,650 | 4,480 | 4,480 | -245 | -5.2% | 791,300 |
| 2018/12/17 | 4,750 | 4,785 | 4,610 | 4,725 | +30 | +0.6% | 850,600 |
| 2018/12/14 | 4,880 | 4,895 | 4,690 | 4,695 | -195 | -4% | 866,700 |
| 2018/12/13 | 4,890 | 4,920 | 4,780 | 4,890 | +25 | +0.5% | 891,000 |
| 2018/12/12 | 4,735 | 4,880 | 4,725 | 4,865 | +115 | +2.4% | 973,500 |
| 2018/12/11 | 4,835 | 4,855 | 4,710 | 4,750 | -65 | -1.3% | 857,000 |
| 2018/12/10 | 4,710 | 4,860 | 4,700 | 4,815 | +60 | +1.3% | 1,060,000 |
| 2018/12/07 | 4,720 | 4,770 | 4,615 | 4,755 | +140 | +3% | 813,200 |
| 2018/12/06 | 4,765 | 4,795 | 4,535 | 4,615 | -195 | -4.1% | 1,009,900 |
| 2018/12/05 | 4,705 | 4,830 | 4,625 | 4,810 | +100 | +2.1% | 1,194,500 |
1601～
1650
件表示中 / 2996件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 169,200円 | +5.0% | +1.5% | 0.00% | 14.48倍 | 4.08倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 202,400円 | +5.9% | +684.6% | 2.72% | 13.44倍 | 1.34倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 日本新薬 | 329,600円 | +3.6% | -15.3% | 3.76% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| キッセイ薬 | 453,500円 | +3.6% | - | 2.65% | 15.28倍 | 0.90倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
